Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).

被引：0
|
作者：
Karasinska, Joanna [1 ]
Kalloger, Steve [2 ]
Wong, Hui-Li [3 ]
Renouf, Daniel [3 ]
Schaeffer, David [4 ]
机构：
[1] Pancreas Ctr BC, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Vancouver, BC, Canada
[4] Vancouver Gen Hosp, Vancouver, BC, Canada
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1893
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [1] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    [J]. MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [2] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [3] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [4] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    [J]. MODERN PATHOLOGY, 2015, 28 : 448A - 448A
  • [5] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 448A - 448A
  • [6] The prognostic significance of preoperative nutritional status in resected pancreatic ductal adenocarcinoma (PDAC)
    Paiella, S.
    Trestini, I.
    Sperduti, I.
    Sandini, M.
    Elio, G.
    Melisi, D.
    Auriemma, A.
    Solda, C.
    Tregnago, D.
    Avancini, A.
    Secchettin, E.
    Bonamini, D.
    Malleo, G.
    Gianotti, L.
    Pilotto, S.
    Bassi, C.
    Milella, M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 726 - 726
  • [7] Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
    Gong Ruining
    Hu Yonglu
    Yu Qian
    Fang Lin
    Ren He
    [J]. 胰腺病学杂志(英文), 2023, 06 (04)
  • [8] Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
    Gong, Ruining
    Hu, Yonglu
    Yu, Qian
    Fang, Lin
    Ren, He
    [J]. JOURNAL OF PANCREATOLOGY, 2023, 6 (04) : 185 - 195
  • [9] Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
    Le, Kai
    Wang, Jia
    Zhang, Tao
    Guo, Yifan
    Chang, Hong
    Wang, Siyuan
    Zhu, Bin
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (04): : 422 - 427
  • [10] Pancreatic ductal adenocarcinoma (PDAC) early detection
    Hinestrosa, Juan P.
    Dhani, Harmeet
    Schroeder, Gregor
    Lewis, Jean M.
    Balcer, Heath I.
    Kurzrock, Razelle
    Keith, Dove
    Sears, Rosalie
    Billings, Paul
    [J]. CANCER RESEARCH, 2023, 83 (07)
12345